144 related articles for article (PubMed ID: 17435219)
1. Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18.
Kwong LN; Shedlovsky A; Biehl BS; Clipson L; Pasch CA; Dove WF
Genetics; 2007 Jun; 176(2):1237-44. PubMed ID: 17435219
[TBL] [Abstract][Full Text] [Related]
2. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development.
Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A
Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047
[TBL] [Abstract][Full Text] [Related]
4. Exclusion of Madh2, Madh4, and Madh7 as candidates for the modifier of Min 2 (Mom2) locus.
Silverman KA; Koratkar RA; Siracusa LD; Buchberg AM
Mamm Genome; 2003 Feb; 14(2):119-29. PubMed ID: 12584607
[TBL] [Abstract][Full Text] [Related]
5. The CAST/Ei strain confers significant protection against Apc(Min) intestinal polyps, independent of the resistant modifier of Min 1 (Mom1) locus.
Koratkar R; Pequignot E; Hauck WW; Siracusa LD
Cancer Res; 2002 Oct; 62(19):5413-7. PubMed ID: 12359746
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
[TBL] [Abstract][Full Text] [Related]
7. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.
Crist RC; Roth JJ; Lisanti MP; Siracusa LD; Buchberg AM
Cell Cycle; 2011 Apr; 10(7):1092-9. PubMed ID: 21386660
[TBL] [Abstract][Full Text] [Related]
8. The ROSA26 LacZ-neo(R) insertion confers resistance to mammary tumors in Apc(Min/+) mice.
Kohlhepp RL; Hegge LF; Moser AR
Mamm Genome; 2001 Aug; 12(8):606-11. PubMed ID: 11471054
[TBL] [Abstract][Full Text] [Related]
9. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
[TBL] [Abstract][Full Text] [Related]
10. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.
Baran AA; Silverman KA; Zeskand J; Koratkar R; Palmer A; McCullen K; Curran WJ; Edmonston TB; Siracusa LD; Buchberg AM
Genome Res; 2007 May; 17(5):566-76. PubMed ID: 17387143
[TBL] [Abstract][Full Text] [Related]
11. Quantitative genetics of age-related retinal degeneration: a second F1 intercross between the A/J and C57BL/6 strains.
Danciger M; Yang H; Ralston R; Liu Y; Matthes MT; Peirce J; Lavail MM
Mol Vis; 2007 Jan; 13():79-85. PubMed ID: 17277741
[TBL] [Abstract][Full Text] [Related]
12. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis.
Oikarinen SI; Cleveland AG; Cork KM; Bynoté KK; Rafter JJ; Gustafsson JA; Mutanen M; Gould KA
Carcinogenesis; 2009 Sep; 30(9):1591-6. PubMed ID: 19574546
[TBL] [Abstract][Full Text] [Related]
13. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
MacPhee M; Chepenik KP; Liddell RA; Nelson KK; Siracusa LD; Buchberg AM
Cell; 1995 Jun; 81(6):957-66. PubMed ID: 7781071
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of variation in adenoma multiplicity in ApcMin/+ Mom1S mice.
Haines J; Johnson V; Pack K; Suraweera N; Slijepcevic P; Cabuy E; Coster M; Ilyas M; Wilding J; Sieber O; Bodmer W; Tomlinson I; Silver A
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2868-73. PubMed ID: 15710876
[TBL] [Abstract][Full Text] [Related]
15. Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.
Koratkar R; Silverman KA; Pequignot E; Hauck WW; Buchberg AM; Siracusa LD
Genomics; 2004 Nov; 84(5):844-52. PubMed ID: 15475263
[TBL] [Abstract][Full Text] [Related]
16. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice.
Gould KA; Dietrich WF; Borenstein N; Lander ES; Dove WF
Genetics; 1996 Dec; 144(4):1769-76. PubMed ID: 8978062
[TBL] [Abstract][Full Text] [Related]
17. Confirmation of provisional quantitative trait loci for voluntary alcohol consumption: genetic analysis in chromosome substitution strains and F2 crosses derived from A/J and C57BL/6J progenitors.
Boyle AE; Gill KJ
Pharmacogenet Genomics; 2008 Dec; 18(12):1071-82. PubMed ID: 19008751
[TBL] [Abstract][Full Text] [Related]
18. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis.
Cormier RT; Hong KH; Halberg RB; Hawkins TL; Richardson P; Mulherkar R; Dove WF; Lander ES
Nat Genet; 1997 Sep; 17(1):88-91. PubMed ID: 9288104
[TBL] [Abstract][Full Text] [Related]
19. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.
Shoemaker AR; Moser AR; Midgley CA; Clipson L; Newton MA; Dove WF
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10826-31. PubMed ID: 9724789
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiota modulates differential adenoma suppression by B6/J and B6/N genetic backgrounds in Apc
Moskowitz JE; Andreatta F; Amos-Landgraf J
Mamm Genome; 2019 Oct; 30(9-10):237-244. PubMed ID: 31549210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
